Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma - Archive ouverte HAL Access content directly
Journal Articles International Journal of Molecular Sciences Year : 2020

Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma

(1) , (1) , (1) , (2) , (3) , (1) , (4) , (1) , (1, 5)
1
2
3
4
5

Abstract

Despite recent advances in therapy, liver metastasis from melanoma is still associated with poor prognosis. Although targeting the mTOR signaling pathway exerts potent anti-tumor activity, little is known about specific mTORC2 inhibition regarding liver metastasis. Using the novel mTORC2 specific inhibitor JR-AB2-011, we show significantly reduced migration and invasion capacity by impaired activation of MMP2 in melanoma cells. In addition, blockade of mTORC2 induces cell death by non-apoptotic pathways and reduces tumor cell proliferation rate dose-dependently. Furthermore, a significant reduction of liver metastasis was detected in a syngeneic murine metastasis model upon therapy with JR-AB2-011 as determined by in vivo imaging and necropsy. Hence, our study for the first time highlights the impact of the pharmacological blockade of mTORC2 as a potent novel anti-cancer approach for liver metastasis from melanoma.
Fichier principal
Vignette du fichier
ijms-22-00030.pdf (4.66 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

hal-03882054 , version 1 (02-12-2022)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Jessica Guenzle, Harue Akasaka, Katharina Joechle, Wilfried Reichardt, Aina Venkatasamy, et al.. Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma. International Journal of Molecular Sciences, 2020, 22 (1), pp.30. ⟨10.3390/ijms22010030⟩. ⟨hal-03882054⟩

Collections

FNCLCC SITE-ALSACE
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More